Report workspace tools

NCT03243006COMPLETEDanonymous

Effect of Early Analgesic Treatment on Opioid Consumption

Sponsor

Source record

University of Monastir

Phase

Source record

NA

Modality

AI-normalized

small molecule

Target

AI-normalized

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Indication / condition

AI-normalized

Acute Pain

Intervention

Source record

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Source & freshness

Source record

NCT ID

NCT03243006

Original source

ClinicalTrials.gov

Source last updated

Nov 30, 2017

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03243006

Title

Effect of Early Analgesic Treatment on Opioid Consumption

Sponsor

University of Monastir

Status

COMPLETED

Phase

NA

Condition raw

Acute Pain

Condition normalized

Acute Pain

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Target normalized

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Interventions

Paracetamol, Tramadol/Paracetamol combination, Placebo Oral Tablet

Public preview

Source record

introduction: Pain remains one of the most common reasons of emergency department admission. Opioids are overprescribed in emergency departments to treat severe pain.

objective: assessing the impact of ealy pain pain management on the use of intravenous morphine and on patient satisfaction.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account

Create a free account first, then unlock a single report, buy credits or subscribe.